Pricing Log in Create free account

Avalo Therapeutics, Inc. (AVTX) vs Rezolute, Inc. (RZLT)

Avalo Therapeutics, Inc. and Rezolute, Inc. are both Biotechnology companies. Avalo Therapeutics, Inc. and Rezolute, Inc. are of similar size ($355.6M and $352.1M). Across the 10 metrics below, Avalo Therapeutics, Inc. leads on 6 and Rezolute, Inc. on 4.

Valuation

Metric AVTX RZLT Biotechnology median
P/E n/m n/m 10.60
P/S 243.01 n/m 9.40
P/B 0.68 3.97 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.94 n/m 0.66
EV/Sales (68.78) n/m 9.02
Earnings yield (68.36%) (19.74%) (32.88%)
Free cash flow yield (45.92%) (16.35%) (23.13%)

Profitability

Metric AVTX RZLT Biotechnology median
Gross margin 64.72% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (36.27%) (59.04%) (51.96%)
Return on assets (32.50%) (53.82%) (46.06%)
Return on invested capital (118.21%) 0.00% 0.00%

Growth

Metric AVTX RZLT Biotechnology median
Revenue growth (TTM) (92.65%) — 6.76%
EPS growth (last fiscal year) 72.07% 23.47% 29.88%
Revenue growth, 5-year CAGR (61.19%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AVTX RZLT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 19.31 9.68 4.97
Net debt to EBITDA 1.36 1.26 1.01

Dividend

Metric AVTX RZLT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AVTX RZLT Biotechnology median
Market cap 355.56m 352.10m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack